Related Experiment Video
Updated: May 9, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance
Eva Maria Putz1, Dagmar Gotthardt, Gregor Hoermann
1Institute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Abstract:
The transcription factor STAT1 is important in natural killer (NK) cells, which provide immediate defense against tumor and virally infected cells. We show that mutation of a single phosphorylation site (Stat1-S727A) enhances NK cell cytotoxicity against a range of tumor cells, accompanied by increased expression of perforin and granzyme B. Stat1-S727A mice display significantly delayed disease onset in NK cell-surveilled tumor models including melanoma, leukemia, and metastasizing breast cancer. Constitutive phosphorylation of S727 depends on cyclin-dependent kinase 8 (CDK8). Inhibition of CDK8-mediated STAT1-S727 phosphorylation may thus represent a therapeutic strategy for stimulating NK cell-mediated tumor surveillance.
Insights
Mutating a specific site on STAT1 enhances natural killer (NK) cell anti-tumor activity. This finding suggests targeting CDK8 could boost NK cell immunity against cancers like melanoma and leukemia.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Natural killer (NK) cells are crucial for innate immunity against tumors and viral infections.
- The transcription factor STAT1 plays a key role in NK cell function.
- STAT1 phosphorylation at serine 727 (S727) influences NK cell activity.
Purpose of the Study:
- To investigate the impact of mutating the STAT1 S727 phosphorylation site on NK cell function and anti-tumor immunity.
- To explore the role of cyclin-dependent kinase 8 (CDK8) in STAT1 phosphorylation.
- To evaluate the therapeutic potential of inhibiting CDK8 for cancer immunotherapy.
Main Methods:
- Site-directed mutagenesis of STAT1 at S727 (Stat1-S727A).
- Assessment of NK cell cytotoxicity against various tumor cell lines.
- Measurement of perforin and granzyme B expression in NK cells.
- In vivo studies using Stat1-S727A mice in tumor models (melanoma, leukemia, breast cancer).
- Pharmacological inhibition of CDK8.
Main Results:
- Mutation of Stat1-S727A significantly enhanced NK cell cytotoxicity.
- Stat1-S727A mutation led to increased expression of cytotoxic effector molecules perforin and granzyme B.
- Stat1-S727A mice exhibited delayed tumor progression in multiple cancer models.
- Constitutive S727 phosphorylation was dependent on CDK8 activity.
Conclusions:
- STAT1 phosphorylation at S727 negatively regulates NK cell cytotoxic function.
- Targeting CDK8 to inhibit STAT1-S727 phosphorylation can enhance NK cell-mediated anti-tumor surveillance.
- Inhibition of CDK8 represents a potential therapeutic strategy for augmenting anti-cancer immunity.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The JAK-STAT Signaling Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

